Use low growth hormone, seizure risk, and the sex distribution clue to sort the differential quickly, and keep the low-grade glioma/meningioma distinction in view when deciding how aggressively to work up the case. The management question is observation versus intervention, not just naming the tumor.

Craniopharyngioma is the classic tumor behind low growth hormone; Low-grade glioma carries the highest seizure risk, especially in the temporal lobe; Stable nonenhancing tumors can often be observed; Ependymomas are more common in men while meningiomas are more common in women; IDH mutation with 1p/19q codeletion predicts the best low-grade glioma prognosis